Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction (vol 2016, 5465678, 2016)

被引：2
|
作者：
Ahmad, Ijaz [1 ,2 ,3 ]
Huang, Lingli [1 ,2 ]
Hao, Haihong [4 ]
Sanders, Pascal [5 ]
Yuan, Zonghui [1 ,2 ,4 ]
机构：
[1] Huazhong Agr Univ, Natl Reference Lab Vet Drug Residues HZAU, Wuhan 430070, Hubei, Peoples R China
[2] Huazhong Agr Univ, MAO Key Lab Detect Vet Drug Residues, Wuhan 430070, Hubei, Peoples R China
[3] Univ Agr Peshawar, Khyber Pakhtunkhwa 25130, Pakistan
[4] Huazhong Agr Univ, MOA Lab Risk Assessment Qual & Safety Livestock &, Wuhan 430070, Hubei, Peoples R China
[5] French Agcy Food Environm & Occupat Safety, Lab Fougeres, F-94701 Maisons Alfort, France
来源：
BIOMED RESEARCH INTERNATIONAL | 2017年 / 2017卷
关键词：
D O I：
10.1155/2017/1408737
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页数：2
相关论文
共 8 条
  • [1] Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction
    Ahmad, Ijaz
    Huang, Lingli
    Hao, Haihong
    Sanders, Pascal
    Yuan, Zonghui
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [2] Comment on "Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction"
    Benini, Anna
    Fumagalli, Guido Francesco
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [3] PK/PD modeling of antisecretory effect of omeprazole and its application in dose regimen optimization
    Cheng, Neng-neng
    Wang, Yongming
    Xu, Guoming
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 203 - 204
  • [4] Application of PK/PD Modeling in Lead Optimization and Human Dose Projection in a Covalent Inhibitor-Based Drug Discovery Project
    Fura, Aberra
    Obermeier, Mary
    Tino, Joe
    Burke, Jim
    Marathe, Punit
    Yang, Zheng
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S3 - S3
  • [5] Modeling and predicting drug resistance rate and strength (vol 35, pg 1259, 2016)
    Fullybright, R.
    Dwivedi, A.
    Mallawaarachchi, I.
    Sinsin, B.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2016, 35 (11) : 1893 - 1893
  • [6] Results from the Survey of Antibiotic Resistance (SOAR) 2016-17 in Ukraine: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints
    Torumkuney, D.
    Bratus, E.
    Yuvko, O.
    Pertseva, T.
    Morrissey, I.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 : 100 - 111
  • [7] Results from the Survey of Antibiotic Resistance (SOAR) 2016-18 in Vietnam, Cambodia, Singapore and the Philippines: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints
    Torumkuney, D.
    Van, P. H.
    Thinh, L. Q.
    Koo, S. H.
    Tan, S. H.
    Lim, P. Q.
    Sivhour, C.
    Lamleav, L.
    Somary, N.
    Sosorphea, S.
    Lagamayo, E.
    Morrissey, I.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 : 19 - 42
  • [8] Translational PK/PD/efficacy modeling and efficacious human dose prediction for a first-in-class MUC1-EGFR (M1231) bispecific antibody drug conjugate
    Zutshi, Anup
    Neuteboom, Berend
    Kumar, Seema
    Sloot, Willem
    Knuehl, Christine
    Dotterweich, Julia
    Ma, Jianguo
    Amendt, Christiane
    Venkatakrishnan, Karthik
    Park, Taeshin
    Pappas, John
    Kim, Kyoung-Ae
    CANCER RESEARCH, 2022, 82 (12)
1